|
|
||||||||
1 attenuates myocardial
ischemia-reperfusion injury via inhibition of upregulation
of MMP-1
1 Departments of Internal Medicine and Physiology, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205-7199; 2 Department of Surgical Sciences, University of Uppsala, Uppsala 75237, Sweden
Ischemia-reperfusion (I/R)
is thought to upregulate the expression and activity of matrix
metalloproteinases (MMPs), which regulate myocardial and vascular
remodeling. Previous studies have shown that transforming growth
factor-
1 (TGF-
1) can attenuate myocardial
injury induced by I/R. TGF-
1 is also reported to
suppress the release of MMPs. To study the modulation of MMP-1 by
TGF-
1 in I/R myocardium, Sprague-Dawley rats were given
saline and subjected to 1 h of myocardial ischemia [total
left coronary artery (LCA) ligation] followed by 1 h of
reperfusion (n = 9). Parallel groups of rats were
pretreated with recombinant TGF-
1
(rTGF-
1, 1 mg/rat, n = 9) before
reperfusion or exposure to sham I/R (control group). I/R caused
myocardial necrosis and dysfunction, indicated by decreased first
derivative of left ventricular pressure, mean arterial blood pressure,
and heart rate (all P < 0.01 vs. sham-operated control group). Simultaneously, I/R upregulated MMP-1 (P < 0.01). Treatment of rats with rTGF-
1 reduced the extent
of myocardial necrosis and dysfunction despite I/R (all
P < 0.01). rTGF-
1 treatment also
inhibited the upregulation of MMP-1 in the I/R myocardium (P < 0.05). To determine the direct effect of MMP-1 on
the myocardium, isolated adult rat myocytes were treated with active
MMP-1, which caused injury and death of cultured myocytes, measured as
lactate dehydrogenase release and trypan blue staining, in a dose- and time-dependent manner (P < 0.05). Pretreatment with
PD-166793, a specific MMP inhibitor, attenuated myocardial injury and
death induced by active MMP-1. The present study for the first time shows that MMP-1 can directly cause myocyte injury or death and that
attenuation of myocardial I/R injury by TGF-
1 may, at
least partly, be mediated by the inhibition of upregulation of
MMP-1.
metalloproteinases; myocardium; transforming growth
factor-
1
This article has been cited by other articles:
![]() |
D. J. Hausenloy and D. M. Yellon Cardioprotective growth factors Cardiovasc Res, July 15, 2009; 83(2): 179 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Frenkel, A. S. Pachori, L. Zhang, A. Dembinsky-Vaknin, D. Farfara, S. Petrovic-Stojkovic, V. J. Dzau, and H. L. Weiner Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury Int. Immunol., July 1, 2009; 21(7): 817 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Dickson, C. P. Hogrefe, P. S. Ludwig, L. W. Ackermann, L. L. Stoll, and G. M. Denning Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H402 - H408. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Cortez, M. D. Feldman, S. Mummidi, A. J. Valente, B. Steffensen, M. Vincenti, J. L. Barnes, and B. Chandrasekar IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP- , NF-{kappa}B, and AP-1 activation Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3356 - H3365. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hu, A. Dandapat, J. Chen, Y. Fujita, N. Inoue, Y. Kawase, K.-i. Jishage, H. Suzuki, T. Sawamura, and J. L. Mehta LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion Cardiovasc Res, November 1, 2007; 76(2): 292 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-P. Hu, A. Dandapat, Y. Liu, P. L. Hermonat, and J. L. Mehta Blockade of hypoxia-reoxygenation-mediated collagen type I expression and MMP activity by overexpression of TGF-beta1 delivered by AAV in mouse cardiomyocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1833 - H1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Mehta and H. Attramadal The TGF{beta} superfamily in cardiovascular biology Cardiovasc Res, May 1, 2007; 74(2): 181 - 183. [Full Text] [PDF] |
||||
![]() |
C. K. Sen, S. Khanna, and S. Roy Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart Cardiovasc Res, July 15, 2006; 71(2): 280 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Day, L. Huang, H. Ye, J. Linden, and M. D. Okusa Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages Am J Physiol Renal Physiol, April 1, 2005; 288(4): F722 - F731. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, J. B. Trudeau, K. J. Schoonover, J. I. Lundin, S. M. Barnes, M. J. Cundall, and S. E. Wenzel Interleukin-13 augments transforming growth factor-{beta}1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts Am J Physiol Cell Physiol, February 1, 2005; 288(2): C435 - C442. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |